Lord, Abbett & Co’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
DGM
Lord, Abbett & Co's ABVX Position: Q3 2026 in Review
Lord, Abbett & Co increased its Abivax (ABVX) stake by 21% in Q3 2026, buying an estimated $241K and bringing the position to 11,500 shares worth $1.14M. The position accounts for ﹤0.01% of the portfolio, ranked #543.
Lord, Abbett & Co first reported a position in ABVX in Q3 2025 and has held it in 5 quarters since. The position peaked at $115M in Q4 2025. 319 funds tracked by Wall St. Rank hold ABVX as of Q3 2026.
- Lord, Abbett & Co held 11,500 shares of Abivax worth $1.14M as of Q3 2026.
- Lord, Abbett & Co bought 2,000 Abivax shares in Q3 2026, an estimated $241K.
- Abivax made up ﹤0.01% of Lord, Abbett & Co's portfolio in Q3 2026, its #543 holding.
- Lord, Abbett & Co first reported a position in Abivax in Q3 2025 and has held it in 5 quarters since.
- Lord, Abbett & Co's Abivax position peaked at $115M in Q4 2025.
- 319 funds tracked by Wall St. Rank held Abivax as of Q3 2026.
Based on Lord, Abbett & Co's 13F filing for Q3 2026, filed 13 Nov 2026.